Posted by AGORACOM-JC
at 7:17 PM on Sunday, February 21st, 2021
ORTHO Regenerative Technologies is a cutting-edge med tech firm that uses its proprietary RESTORE technology platform to dramatically improve the success rate of orthopedic and sports medicine surgeries.
In layman’s terms, that means company has a wonder delivery platform that delivers biologics – drugs made from biological processes – to repair soft tissues in the human body.
The technology uses biologics derived from things like plasma and bone marrow concentrate to regenerate new tissue in various musculoskeletal conditions.
This includes Wound Healing, Cartilage repair and Osteo-arthritis
So, how big is the market opportunity for Soft Tissue Repair? At least $5bn in the U.S. alone. This includes:
Rotator Cuff TEAR (which leads to shoulder dysfunction and pain):
4m patients in the U.S. alone
600,000 annual surgeries in the U.S. alone
$600m+ market opportunity
Meniscus Tear Repair (which is painful and compromises knee function):
There are 1.2m surgeries annually in U.S. alone
$1bn+ market opportunity
Cartilage Lesions Repair (this is where lesions cause friction and pain):
1.2m detected lesions annually in U.S. alone
120,000 surgeries and a lack of options
$1bn+ market opportunity
Get comfy for this insightful interview with Claude LeDuc, Ortho’s CEO.
Posted by AGORACOM-JC
at 1:20 PM on Tuesday, December 10th, 2019
SPONSOR: NORTHBUD (NBUD:CSE)
Sustainable low cost, high quality cannabinoid production and
procurement focusing on both bio-pharmaceutical development and
Cannabinoid Infused Products. Learn More.
Posted by AGORACOM-JC
at 4:50 PM on Friday, November 22nd, 2019
SPONSOR: NORTHBUD (NBUD:CSE)
Sustainable low cost, high quality cannabinoid production and
procurement focusing on both bio-pharmaceutical development and
Cannabinoid Infused Products. Learn More.
Over the past month, lobbyists have beat a path to Ontario’s legislature to discuss – among other things related to cannabis – taxation, labor policies, law enforcement and how adult-use marijuana is sold in the province
Punished by disappointing sales due to a lack of retail stores, the
cannabis industry has been mounting a fierce lobbying drive in Ontario
to reach the decisionmakers driving the province’s marijuana policies,
according to records from the Office of the Integrity Commissioner.
Over the past month, lobbyists have beat a path to Ontario’s
legislature to discuss – among other things related to cannabis –
taxation, labor policies, law enforcement and how adult-use marijuana is
sold in the province.
The records show that efforts have been made to reach Ontario’s power brokers by:
Aurora Cannabis
Aphria
Convenience Industry Council of Canada
Cronos Group
The Green Organic Dutchman
Insurance Bureau of Canada
LeafLink
Loblaw
Supreme Cannabis Co.
Truss
Meanwhile, a former member of the ruling Progressive Conservative
caucus is urging the party to adopt a clearer timeline for the planned
pivot to an open allocation of adult-use retail stores.
Independent MPP Randy Hillier said Ontario’s bungled cannabis
policies are costing the province, and its businesses, millions in lost
economic opportunities.
“Here we have a government that promotes itself as ‘open for
business,’ and what is the biggest impediment in the cannabis trade
right now? Government’s lack of action and preventing people (from)
opening retail establishments,†the independent MPP said in an
interview.
He called Ontario’s cannabis lottery a “cluster you-know-what.â€
The fledgling industry has already lost out on hundreds of millions
of dollars of revenue, according to Craig Wiggins, managing director of
market researcher TheCannalysts.
That has caused some producers to scale back production.
Hillier called on the government to empower the Alcohol and Gaming Commission of Ontario to license cannabis stores.
“We have 24 stores in operation a year out from legalization to serve
14 million people,†he said. “Newfoundland, with a population of
500,000 people, has as many stores as Ontario. Saskatchewan has twice as
many with a population of a million people.
“We’re not achieving what we set out to with the legalization of
cannabis, which is to get it out of the criminal marketplace. We’re
allowing the criminal marketplace to continue to thrive.â€
Ontario’s recent Economic Outlook restated the commitment to “an open
allocation of cannabis retail store licenses where the number of stores
is limited only by market demand,†however no timeline was offered.
Hillier’s advice to legal cannabis businesses is to speak up.
“If government policies are creating barriers for your businesses, then speak out.
“Bark as loud as possible, and possibly bite. That’s what often
motivates government, is fear of embarrassment and fear of having to
justify their actions.â€
Matt Lamers is Marijuana Business Daily’s international editor, based near Toronto, Ontario. He can be reached at [email protected].
Posted by AGORACOM-JC
at 2:44 PM on Monday, November 11th, 2019
SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.
Welcome to the Cannabis Countdown.
In this week’s rendition, we’ll recap and countdown the top 10
marijuana industry news stories for the week of November 4th – 10th,
2019.
Multi-Platinum Recording Superstar Drake and Canopy Growth Announce New Cannabis Partnership
Drake is heading home and will own a majority stake in Toronto-based “More Life Growth”. Canopy Growth (TSX: WEED) (NYSE: CGC) will own the remaining 40% in the new fully licensed cannabis producer.
READ FULL DRAKE ARTICLE
9. Passengers Carrying Cannabis on Air Canada’s Toronto to Vancouver Flight Shocked When Plane Got Re-Routed to U.S.
Foggy Conditions Forced Flight AC 125 to Land at Seattle Airport with Some Passengers Carrying Cannabis and CBD
One legal expert gives advice to Canadians on how to handle an extraordinary situation like this.
READ FULL AIR CANADA ARTICLE
8. Mexico Has Until April 30 to Legalize Cannabis, Supreme Court Rules
That Legislation Proposed Rules Limiting Foreign Ownership, Vertical Integration and License Resale
Mexico’s Supreme Court gave Congress another six months to approve
legislation that legalizes all forms of cannabis, postponing until the
end of April the deadline for when the Latin American country would
create the world’s largest adult-use market by population.
READ FULL MEXICO ARTICLE
7. Canopy Growth Downsizes Latin America Workforce as Region Struggles to Generate Revenue
Investors Have Sent a Clear Message They Want Companies to be More Prudent in Their Spending
One of the largest cannabis companies in the world, Canopy Growth (TSX: WEED) (NYSE: CGC),
is restructuring its overseas operations by laying off 15% of its
workforce in Latin America, reflecting the slow pace at which
revenue-generating opportunities and regulatory structures are evolving
in the region.
READ FULL CANOPY GROWTH ARTICLE
6. FDA Won’t be Hurried to Create CBD Exceptions Amid Safety Concerns
The Agency’s Biggest Concern is Whether CBD is Safe to Consume in Food and Supplements
A top official for the U.S. Food and Drug Administration (FDA) said
the agency is concerned that developing a legal exception for
supplements containing CBD could send the wrong message, both to
companies interested in entering the market and consumers.
READ FULL FDA CBD ARTICLE
5. Ontario Business Group Wants ‘Clear Timeline’ for Cannabis Store Expansion
So Far, Ontario Has Used a Botched Lottery System to Award Licenses to Open Recreational Marijuana Stores
A group comprised of cannabis industry leaders and experts is calling
on Ontario’s government to provide a more complete timetable for when
retail stores will be permitted through an open allocation of licenses.
READ FULL ONTARIO ARTICLE
4. Michigan Nets 52 Adult-Use Marijuana Applications on First Day
State Regulators Expect the First License to be Issued Before the End of November
Marijuana regulators in Michigan received 52 recreational cannabis
business license applications on the first day of the application
period.
READ FULL MICHIGAN ARTICLE
3. Cannabis Canada: Pot Industry Added Nearly Billion to GDP in August
Cannabis Sales in Canada Expected to Double Next Year to $3.16 Billion
Canaccord Genuity cannabis analyst Matt Bottomley expects revenue in
Canada’s legal pot sector to more than double next year despite
slower-than-expected growth. Bottomley said in a research note to
clients that Canada’s cannabis industry should expect $3.16 billion in
revenue in 2020, up from the $1.46 billion forecast for 2019.
READ FULL CANADA STATS ARTICLE
2. U.S. Senate Approves Legislation Protecting State-Legal Medical Cannabis Programs from Federal Interference
Supporters Hope Similar Protection for Recreational States Will Be Included in Final Version Sent to President Trump
The U.S. Senate passed a spending bill extending a provision that
protects medical cannabis states from federal interference. It’s unknown
if the broader House approved protections for adult-use state cannabis
programs will be included in the final version of the bill that’s passed
along to President Trump.
READ FULL MMJ SENATE ARTICLE
1. Breakthrough in CDC Vape Crisis Investigation
Vitamin E Acetate Linked to THC May Be to Blame
Vitamin E acetate, an additive sometimes used in THC and other vaping
products, may be to blame for a national vape crisis of
e-cigarette-related lung injuries that’s linked to dozens of deaths,
according to U.S. Centers for Disease Control and Prevention officials.
Posted by AGORACOM-JC
at 4:50 PM on Wednesday, November 6th, 2019
Annual General and Special Meeting at 1:00 p.m. on Monday, December 16, 2019 at the office of McMillan LLP World Exchange Plaza, Suite 2000, Ottawa, Ontario. Â
Announce that on November 6, 2019, the board authorized the issuance of up to 4,000 convertible debenture units of the Company at a price of $1,000 per Unit for total gross proceeds of up to $4,000,000.
TORONTO, Nov. 06, 2019 — North Bud Farms Inc.(CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) today announces that the Company will hold its Annual General and Special Meeting at 1:00 p.m. on Monday, December 16, 2019 at the office of McMillan LLP World Exchange Plaza, Suite 2000, Ottawa, Ontario. Â
Additionally, the Company is pleased to announce that on November 6,
2019, the board authorized the issuance of up to 4,000 convertible
debenture units (“Unitsâ€) of the Company at a price of
$1,000 per Unit for total gross proceeds of up to $4,000,000. Based on
this decision the Company will not be closing any additional tranches of
the previously announced equity private placement.
Each Unit is comprised of one $1,000 principal amount of secured convertible debenture (a “Convertible Debentureâ€)
accruing interest at 10.0% per annum, payable semi-annually in arrears
until maturity, and 2,000 common share purchase warrants of the Company
(each, a “Warrantâ€). The Convertible Debentures will have a maturity date of 36 months from the date of issuance.
Each Convertible Debenture shall be convertible into common shares in the capital of the Company (each, a “Conversion Shareâ€) at a price of $0.30 per Conversion Share.
Each Warrant entitles the holder thereof to acquire one common share in the capital of the Company (each, a “Warrant Shareâ€) for an exercise price of $0.25 per Warrant Share for a period of 18 months following the closing date.
The Convertible Debentures are direct secured obligations of the Company and rank pari passu in right of payment of principal and interest with all other Convertible Debentures issued under the Offering.
The Company is pleased to announce that on November 6, 2019 it closed
an initial tranche of 1,264 Units for gross proceeds of $1,264,000.
These Units were purchased by one insider and existing shareholders. The
Company intends to close the remaining Units in one or more tranches
over the coming weeks.
Ryan Brown, the Chief Executive Officer, of the Company participated
in the private placement and beneficially acquired 664 Units for a total
proceeds of $664,000. The purchase constitutes a “related party
transaction†within the meaning of Multilateral Instrument 61-101 –
Protection of Minority Security Holders in Special Transactions (“MI 61-101â€).
The issuance is exempt from the formal valuation and minority
shareholder approval requirements of MI 61-101 as the fair market value
of the Units issued to or the consideration paid by such insider did not
exceed 25% of the Company’s market capitalization.
Certain finders (the “Findersâ€) received a cash
commission on the sale of the Offering of $48,000. The Finders also
received 48,000 compensation warrants (the “Compensation Warrantsâ€),
each carrying the right to purchase 3.3333 common shares in the capital
of the Company at a price of $1.00 per Compensation Warrant for a
period of 18 months from the closing date.
The proceeds of the Offering will be used by the Company for
expansion of the Company’s facilities and for general corporate and
working capital purposes.
The Convertible Debentures, Warrants and Compensation Warrants issued
pursuant to the Offering and any common shares in the capital of the
Company issued on conversion of the Convertible Debentures or exercise
of the Warrants or Compensation Warrants are subject to a statutory hold
period in Canada of four months and one day following the closing date
in accordance with applicable securities laws, which shall expire on
March 7, 2020. Additional resale restrictions may be applicable under
the laws of other jurisdictions, if any.
The securities of the Company have not been and will not be
registered under the United States Securities Act of 1933, as amended
(the “U.S. Securities Actâ€) or any state securities
laws. Accordingly, the securities of the Company may not be offered or
sold within the United States unless registered under the U.S.
Securities Act and applicable state securities laws or pursuant to an
exemption from the registration requirements of the U.S. Securities Act
and applicable state securities laws. This news release does not
constitute an offer to sell or a solicitation of an offer to buy any of
the securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Corporate Update Since the submission of our
evidence package to Health Canada, the Company has received some minor
comments from the regulators all of which have been responded to within
24 hours. The Company will update shareholders with any material
developments related to the application process.
About North Bud Farms Inc. North Bud Farms Inc.,
through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a
licence under The Cannabis Act. The Company has built a
state-of-the-art purpose-built cannabis production facility located on
135 acres of Agricultural Land in Low, Quebec, Canada. NORTHBUD through
its wholly owned U.S. subsidiary, Bonfire Brands USA has entered into
agreements to acquire assets in California and Nevada.
Neither the Canadian Securities Exchange (the “CSEâ€) nor its
Regulation Services Provider (as that term is defined in the policies of
the CSE) accepts responsibility for the adequacy or accuracy of this
release.
Forward-looking statements Certain statements
included in this press release constitute forward-looking information or
statements (collectively, “forward-looking statementsâ€), including
those identified by the expressions “anticipateâ€, “believeâ€, “planâ€,
“estimateâ€, “expectâ€, “intendâ€, “mayâ€, “should†and similar expressions
to the extent they relate to the Company or its management. The
forward-looking statements are not historical facts but reflect current
expectations regarding future results or events. This press release
contains forward- looking statements that include, but are not limited
to, statements related to the intended use of proceeds from the
Offering. These forward-looking statements are based on current
expectations and various estimates, factors and assumptions and involve
known and unknown risks, uncertainties and other factors. Such risks and
uncertainties include, among others, the risk factors included in North
Bud Farms Inc.’s final long form prospectus dated August 21, 2018,
which is available under the issuer’s SEDAR profile at www.sedar.com.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT: North Bud Farms Inc. Edward Miller VP, IR & Communications Office: (855) 628-3420 ext. 3 [email protected]
Tags: Cannabis, CBD, CSE, Hemp, Marijuana, otc, stocks, tsx, tsx-v, weed Posted in North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Announces Annual General and Special Meeting on December 16th and the Closing of the First Tranche of its Non-Brokered Private Placement of Secured Convertible Debenture Units $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 4:00 PM on Thursday, October 31st, 2019
SPONSOR: NORTHBUD (NBUD:CSE)
Sustainable low cost, high quality cannabinoid production and
procurement focusing on both bio-pharmaceutical development and
Cannabinoid Infused Products. Learn More.
Edible CBD Products Offer Consumers a New Health Trend
North American consumer spending on cannabis-infused foods and drinks reached USD 1.5 Billion in 2018, according to data compiled by Arcview Market Research and BDS Analytics,
By 2022, the two firms suggest that edible sales are on track to reach USD 4.1 Billion
NEW YORK, Oct. 31, 2019 – Consumer trends constantly require industries to adapt in order to thrive among the competition. Specifically, the food and beverage industry is one of the fastest evolving markets because of constant changes in consumer demands. Nowadays, the increasing demand for healthier and more organic options is prompting manufacturers to produce alternatives to sugar-packed drinks and fatty snacks. Instead, consumers are looking for products that are processed with healthier sustainable ingredients, proteins, vitamins, and antioxidants. Notably, many consumers have turned to the beverage industry for functional drinks such as kombucha. A functional drink is a type of beverage that typically conveys a health benefit such as being packed with performance-enhancing agents like nootropics and amino acids. Consequently, the growing demand in the functional beverage market sparked interest within the CBD market. CBD is a derivative of the hemp plant, which falls under the cannabis family.
Typically, cannabis is associated with its marijuana component, which
causes psychoactive effects because of its heavy THC concentrate.
However, hemp does not cause psychoactive effects because the main
compound is CBD. THC and CBD are widely different in their biological
makeup, but because they derive from the cannabis plant, regulators
deemed both compounds to be unsafe for consumers. However, extensive
research has uncovered that CBD provides therapeutic and health
benefits, which then led to the rapid emergence of CBD-based products.
As such, North American consumer spending on cannabis-infused foods and
drinks reached USD 1.5 Billion in 2018, according to data
compiled by Arcview Market Research and BDS Analytics, By 2022, the two
firms suggest that edible sales are on track to reach USD 4.1 Billion.
Typically, most people consume CBD to simply relax. However, clinical
trials have proven that CBD can also provide medical benefits.
Specifically, patients suffering from chronic ailments such as severe
pain, cancer, arthritis, and epilepsy can consume CBD drinks to subdue
the symptoms. And while CBD is quickly permeating throughout global
regions, the North American market is the primary driver because of
legality stance. Canada moved to legalize cannabis entirely
back in late 2018, which prompted a spur of recreational demand. On the
other hand, the U.S. passed the Farm Bill in 2018, which legalized
hemp-derived CBD products. Shortly after, stores across the nation began
to commercialize CBD goods.
Now, consumers can easily purchase products such as tinctures,
topicals, oils, and edibles at their local convenience stores or online
e-commerce platforms. However, the CBD beverage market is one of the
most popular segments because consumers can easily purchase a CBD-based
tincture and add droplets of CBD into their beverage. Generally, CBD can
be found within beverages such as soda, juice, coffee, wine, water, and
even alcohol. However, consumers can also add CBD-based powders into
their beverages and some producers have even mentioned that powders are
much better in terms of solubility. Overall, the cannabis-infused
beverage industry is quickly gaining traction, however, some beverage
producers are still evaluating the industry.
Nonetheless, a handful of corporations such as the alcohol industry,
have already dove into the marketplace and are already marking their
presence. “Everyone in the industry recognizes that CBD-infused
beverages are going to be one of the largest category opportunities in
all of CBD,” said Ben Witte, the Founder and Chief
Executive Officer of Recess, a company producing CBD-infused sparkling
water. “As a result of that, a lot of the suppliers in the supply chain
have innovated to create a format that is soluble in beverages.”
Posted by AGORACOM-JC
at 10:26 AM on Friday, October 18th, 2019
SPONSOR: NORTHBUD (NBUD:CSE)
Sustainable low cost, high quality cannabinoid production and
procurement focusing on both bio-pharmaceutical development and
Cannabinoid Infused Products. Learn More.
‘It is quite amazing’: CBD oil entering the mainstream
Some people are infusing the cannabis extract in cocktails, others
are buying it in the form of dog treats, while many more are using it as
a form of pain relief.
Unlike tetrahydrocannabinol, the psychoactive extract of the cannabis
plant commonly known as THC, cannabidiol doesn’t cause users to get
high.
And it is legal in the UK, assuming it does not contain one part in 10,000 of THC.
“When I first got involved with CBD I wanted to know what it was all
about,†says Richard Butler, part of the management team at CBD Virtue,
between Bridgnorth and Wolverhampton.
“It is still new in the UK.â€
Some of the products
His company uses CBD to make products such as tablets, oils, body creams and balms.
Mr Butler says people are turning to CBD products to alleviate
symptoms from physical ailments like pain and inflammation as well as
mental ones like anxiety and depression.
At present, use of the oil is largely unregulated, and clinical
trials into its usefulness are ongoing, but Mr Butler says he has
witnessed its benefits.
“You learn more from the responses and feedback you get from
customers,†he says. “It helps with pain relief, mental issues,
anxieties.
“It also helps with eczema, psoriasis and acne – it is quite amazing actually.
“A lot of our initial customers were 40 plus and many were buying products for the younger generation.
Dean Burke using a CBD Pod Filler at CBD Virtue
“What has amazed me is the amount of depression and anxiety that exists among teenagers up to people in their late 20s.â€
CBD oil, its proponents say, offers numerous benefits, from pain
relief to reducing anxiety. As an anticonvulsant, it may also help treat
neurological disorders such as epilepsy and multiple sclerosis.
CBD is also one of the biggest buzzwords in food and drink. It has
been hailed the next big thing, with more and more chefs and producers
using the products in their recipes.
After already taking other countries by storm, more businesses in the UK are looking to tap into the market.
Ross Burke viewing the product range at CBD Virtue
Mr Butler insists he has seen some significant success stories of people using the product for remedial purposes.
“I know someone who suffered with Parkinson’s for years who every
time they woke up their whole body would be shaking and during the day
they would shake out of control,†he says.
“I said ‘try this’ and within two weeks they went from their whole
body shaking to feeling a slight twitch in their first finger and thumb.
“I am not allowed to say it cures cancer, but cancer sufferers are
using it. There was someone who had skin cancer and it helped clear up
blisters on their skin.
“My partner was on a lot of medication for various things and after
taking four or five drops a day her stress and anxiety has gone.â€
The product’s relationship to recreational cannabis also means that
some people are reluctant to accept its use, and the medical benefits it
provides have still to be proven beyond doubt.
But Mr Butler insists that the hemp-derived oil should be trusted.
“It is from a natural product that has been around for years,†he
says. “Initially people were sceptical because it relates to cannabis.
Yes, it is derived from cannabis plant, but the ‘high’ has been removed
with the remedial side left behind.
The management team at CBD Virtue: Dean Burke, Richard Butler, Shannon Fyfe and Ross Burke
“We had the over 50s saying ‘ yeah but it’s cannabis, it’s cannabis’,
but once you have explained to them they are willing to try it.
“A big part of my role has been educational. I would spend about two
hours a day on Facebook educating people and answering a lot of
questions.
“Initially it is getting people to try it, then after they see how
effective it is they speak about it to their friends and family – a lot
of it comes down to word of mouth.â€
The plant is grown in Colorado in the USA, and a powdered form of the
product is sent to the UK for the oil to be extracted by Richard’s
team.
CBD Virtue employs 16 people, and is looking to double that by moving to larger premises to cope with demand.
Richard says: “We have a lab which is about 15ft by 20ft where a lot
of our mixing is done. We also have another facility where we do the
bottling up and everything else.
Jean Price packing up an order at CBD Virtue
“We are looking for larger premises due to growing demand and want to
stay local. We employ 16 people and with the way things are going we
are looking to double the workforce.â€
Sales of products containing CBD have skyrocketed by 99 per cent in the UK, according to data.
Analysis by deals firm Wowcher suggests purchases of CBD products
have almost doubled in 2019, with an increasing number of Brits trying
the ingredient.
“The industry is exploding,†Mr Butler says. “Initially as a company
we had a slow start with various issues with banks and online payment
systems, but we have got more and more people on board who know how to
get around these things.
Posted by AGORACOM-JC
at 10:03 AM on Thursday, October 17th, 2019
Announce the appointment of Sean Homuth as Acting Chief Financial Officer, effective today
Mr. Homuth’s permanent role as CFO will commence upon receiving Health Canada security clearance required for all Officers and Directors of the Company
TORONTO, Oct. 17, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) is pleased to announce the appointment of Sean Homuth as Acting Chief Financial Officer (CFO), effective today. Mr. Homuth’s permanent role as CFO will commence upon receiving Health Canada security clearance required for all Officers and Directors of the Company.Â
“As NORTHBUD expands its presence into the USA with the anticipated
closing of its previously announced letters of intent with the Qlora
Group (California) and Nevada Botanical Science (Nevada), we are
strategically adding additional expertise in international business and
finance,†said Ryan Brown, CEO of North Bud Farms Inc.
Mr. Homuth brings extensive experience with both Canadian and U.S.
publicly traded organizations both in industry as well as from a client
perspective during his tenure at Ernst & Young and, more recently,
as an independent consultant. Previously, Mr. Homuth was Chief Financial
Officer at Orezone Gold Corporation (and Vice President, Finance and
Administration for its predecessor company, Orezone Resources Inc.) a
publicly listed company headquartered in Canada with operations in West
Africa. At Orezone Mr. Homuth led a global team of finance professionals
and was involved in over $800 million in financings and M&A
transactions with the company and its predecessor. Mr. Homuth holds
accounting designations in both Canada (CPA, CA) and the United States
(CPA – Illinois).
“We are pleased to welcome Sean to our dynamic team as NORTHBUD
expands its footprint into the USA,†stated Ryan Brown, CEO of North Bud
Farms Inc. “Sean brings specialty experience in accounting and finance
for international companies as well as a profound knowledge of capital
markets, having worked with and advised many public companies over the
years. He joins NORTHBUD at an exciting time in its development as his
leadership and experience will be essential in executing our strategic
plan and taking the company to its next level of growth.â€
Brendan Stutt, the Company’s incumbent CFO, who has made invaluable
contributions to the Company’s financial leadership and culture, will
work to ensure a smooth transition and will remain with the Company in a
non-executive role.
Mr. Brown stated: “We would like to thank Brendan for his
contributions to the Company, in particular the successful listing of
NORTHBUD on the Canadian Securities Exchange.â€
About North Bud Farms Inc. North Bud Farms Inc.,
through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a
licence under The Cannabis Act. The Company has built a state-of-the-art
purpose-built cannabis production facility located on 135 acres of
Agricultural Land in Low, Quebec, Canada. NORTHBUD through its wholly
owned U.S. subsidiary, Bonfire Brands USA has entered into agreements to
acquire assets in California and Nevada.
Neither the Canadian Securities Exchange (the “CSEâ€) nor its
Regulation Services Provider (as that term is defined in the policies of
the CSE) accepts responsibility for the adequacy or accuracy of this
release.
Forward-looking statements Certain statements and
information included in this press release that, to the extent they are
not historical fact, constitute forward-looking information or
statements (collectively, “forward-looking statementsâ€) within the
meaning of applicable securities legislation. Forward-looking
statements, including those identified by the expressions “anticipateâ€,
“believeâ€, “planâ€, “estimateâ€, “expectâ€, “intendâ€, “mayâ€, “should†and
similar expressions to the extent they relate to the Company or its
management. This press release contains forward- looking statements
including those relating to the entering into of the Definitive
Agreement and closing of the Transaction with the Qlora Group and Nevada
Botanical Science. Forward-looking statements are based on the
reasonable assumptions, estimates, analysis and opinions of management
made in light of its experience and its perception of trends, current
conditions and expected developments, as well as other factors that
management believes to be relevant and reasonable in the circumstances
at the date that such statements are made, but which may prove to be
incorrect.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the Company to differ materially from any
future results, performance or achievements expressed or implied by the
forward-looking statements. Such risks and uncertainties include, among
others, the risk factors included in the Company’s final long form
prospectus dated August 21, 2018, which is available under the Company’s
SEDAR profile at www.sedar.com.
Accordingly, readers should not place undue reliance on any such
forward-looking statements. Further, any forward-looking statement
speaks only as of the date on which such statement is made. New factors
emerge from time to time, and it is not possible for the Company’s
management to predict all of such factors and to assess in advance the
impact of each such factor on the Company’s business or the extent to
which any factor, or combination of factors, may cause actual results to
differ materially from those contained in any forward-looking
statements. The Company does not undertake any obligation to update any
forward-looking statements to reflect information, events, results,
circumstances or otherwise after the date hereof or to reflect the
occurrence of unanticipated events, except as required by law including
securities laws. This news release does not constitute an offer to sell
or a solicitation of any offer to buy any securities of the Company.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT: North Bud Farms Inc. Edward Miller VP, IR & Communications Office: (855) 628-3420 ext. 3 [email protected]
Tags: Cannabis, CBD, CSE, Hemp, Marijuana, otc, stocks, tsx, tsx-v, weed Posted in North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Announces the Appointment of Sean Homuth as Acting Chief Financial Officer $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 12:55 PM on Wednesday, October 9th, 2019
SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.
PODCAST: Why ‘cannabis 3.0’ is the real opportunity for Canada with Bruce Linton
Welcome to Down to Business, a weekly podcast from the Financial Post.
It’s been one year since Canada legalized the recreational cannabis
industry after a century of prohibition. But it’s just the beginning of
the journey from the black market to “cannabis 3.0.â€
In the lead-up to the election, Down to Business has focused on
business issues with a political twist. This week, host Emily Jackson
discusses the cannabis industry’s one-year legalization anniversary with
Bruce Linton, the former chief executive of Canopy Growth, Canada’s
largest cannabis company.
Linton discusses lessons from the first round of legalization for
recreational use, what to expect from the impending introduction of
cannabis infused beverages and edibles, and why Canada needs to focus on
“cannabis 3.0†if it wants to be a global leader.
Tags: Cannabis, CBD, CSE, Hemp, Marijuana, otc, stocks, tsx, tsx-v, weed Posted in North Bud Farms Inc | Comments Off on PODCAST: Why #cannabis 3.0 is the real opportunity for Canada with Bruce Linton – SPONSOR: #NORTHBUD $NBUD.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca
Posted by AGORACOM-JC
at 12:07 PM on Thursday, October 3rd, 2019
SPONSOR: NORTHBUD (NBUD:CSE)
Sustainable low cost, high quality cannabinoid production and
procurement focusing on both bio-pharmaceutical development and
Cannabinoid Infused Products. Learn More.
Canada’s legalization of pot edibles later this year is facing an even more shambolic start than the dried flower market, which is still struggling to meet demand, according to industry players.
Kristine Owram, Bloomberg News
Canada’s legalization of pot edibles later this year is facing an
even more shambolic start than the dried flower market, which is still
struggling to meet demand, according to industry players.
“At least that time we knew what the permissible product types were
going to be and were already making them in the medical context,†said
cannabis lawyer Trina Fraser, a partner at Brazeau Seller Law in Ottawa.
Canada will add edibles, extracts and topicals to the list of legal
cannabis products no later than Oct. 17. Many analysts agree these
products will generate better demand and margins than dried flower. But
the federal government has not yet issued regulations for the new
formats, making it difficult for producers to prepare lest they
unknowingly violate some rule.
A spokeswoman for Health Canada declined to comment on when the regulations will be released.
In addition, a huge licensing backlog has built up at Health Canada,
the government agency that oversees cannabis regulations. About 614
applications were waiting in the queue as of March 31.
“A full rollout amongst a nice wide array of producers and a wide
array of these new product types is going to take time, literally years,
because we have such a licensing backlog,†Fraser said.
Company Stockpiling
Canada’s market for edibles and other alternative pot produces will
eventually be worth C$2.7 billion ($2 billion) annually, but consumers
should expect “missteps, delays and frustration†in the early days,
Deloitte said in a report published Monday. Jennifer Lee, Deloitte
Canada’s cannabis national leader, estimated it will be a minimum of 24
months before the industry normalizes.
In the meantime, many pot companies are stockpiling, choosing to
forgo revenue today to ensure they have enough supply for the new
high-value products. This is exacerbating the shortage of dried flower,
but executives say it’s worth it.
“We’ve made a very conscious effort to delay revenue,†said Chuck
Rifici, chief executive officer of Auxly Cannabis Group Inc. Selling
into the market today doesn’t build brand recognition because shelves
are empty and consumers are buying whatever’s available, he added. “I
would much rather save that product, get a multiple of margin on that
brand and make sure that I have enough inventory.â€
Lab Delays
This is proving to be a boon for extraction companies like Valens
GroWorks Corp. Valens has contracts with many of the biggest pot
companies, including Canopy Growth Corp., Hexo Corp. and Tilray Inc., to
extract cannabis oil from their plants, which is then used for products
like edibles and vape cartridges. It’s also investing heavily in its
testing labs in the belief that Health Canada will have stringent
regulations to ensure pesticides and other contaminants don’t make it
into the new consumer products.
“Even in labs today there’s delays where people are waiting three
weeks to a month to get lab results back and I think that will only get
worse,†said Everett Knight, Valens’ executive vice president of
strategy and investments.
Companies are also making big bets on what products will be in
demand, with Canopy and Hexo leaning toward cannabis beverages and
others toward vaping.
Be Prepared
“Why do I want an edible or a drink when I can have a vape?†Irwin
Simon, interim CEO of Aphria Inc., said in an interview on the sidelines
of a cannabis conference last month. “I see the margins and the
opportunities there.â€
Rifici at Auxly also believes vape pens will be “the most important
category by far.†But there are many unanswered questions. For example,
will the government require companies to engrave its mandatory THC
warning symbol into the pen itself, or will a sticker suffice?
This is why Valens is offering its customers 196 different options
for its white-label vape pens. “You’ve got to make sure you cover your
bases and prepare for all the possibilities,†Knight said.
Despite the uncertainty, it’s better to be prepared even if plans and
production lines have to be tweaked once the regulations come out, said
Bruce Linton, CEO of Canopy, which is building a 197,000 square foot
bottling plant for cannabis beverages in Smiths Falls, Ontario.
“We’re in a situation where it’s better to spend money to be ready than to save money and be late,†he said.
Cannabis Canada is BNN Bloomberg’s in-depth
series exploring the stunning formation of the entirely new – and
controversial – Canadian recreational marijuana industry. Read more from
the special series here and subscribe to our Cannabis Canada newsletter to have the latest marijuana news delivered directly to your inbox every day.